Related Experiment Videos
Slow migrating proteinase inhibitors in human serum
Hoppe-Seyler'S Zeitschrift Fur Physiologische Chemie
|May 1, 1984
Summary
Two new trypsin inhibitors were discovered in human serum, appearing in patients with various diseases but not in healthy individuals. These inhibitors also target pancreatic elastase, suggesting a role in disease-related proteinase activity.
Area of Science:
- Biochemistry
- Clinical Chemistry
- Proteomics
Background:
- Serum protein analysis is crucial for diagnosing and understanding various pathological conditions.
- Proteinase inhibitors play vital roles in regulating enzymatic activity and maintaining physiological balance.
Purpose of the Study:
- To identify and characterize previously unrecognized trypsin inhibitors in human serum.
- To investigate the presence of these inhibitors in different disease states and their potential targets.
Main Methods:
- Utilized a sensitive semi-quantitative electrophoretic technique on acid-deproteinized serum.
- Analyzed native serum for the presence of inhibitory bands.
- Conducted immunological investigations using antibodies against known proteinase inhibitors.
- Assessed the inhibitory activity against pancreatic elastase.
Main Results:
- Identified two novel trypsin inhibitors migrating as beta 2- and gamma-globulins in serum.
- These inhibitors were detected in patients with uremia, cancer, inflammatory diseases, and collagenosis, but not in healthy controls.
- No cross-reactivity was observed with antibodies against seven common proteinase inhibitors.
- Both identified inhibitors demonstrated inhibitory activity against pancreatic elastase.
Conclusions:
- Two new serum trypsin inhibitors have been identified, distinct from known proteinase inhibitors.
- Their presence in various disease states suggests a potential role in the pathogenesis of these conditions.
- The dual inhibition of trypsin and pancreatic elastase highlights their significance in protease regulation.